Get a free sample of Injectable Contraceptives Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Injectable Contraceptives Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Injectable Contraceptives Market Size
Injectable Contraceptives Market size was valued to be USD 339.5 million in 2022 and is predicted to experience a sustainable growth of CAGR 3.5% from 2023 to 2032. Some of the major factors contributing to the growth of global market are growing awareness about family planning that is leading to an increase in awareness about benefits of injectable. Furthermore, the efforts undertaken by government and other organisations to enhance the availability of injectable contraceptives are contributing to the market expansion.
Injectable contraceptives are a type of birth control method that involves the administration of hormones through an injection to prevent pregnancy. These hormones typically include progestin, a synthetic form of the hormone progesterone. Injectable contraceptives are mainly available in two forms, depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN).
Who are the key injectable contraceptives industry players?
Pfizer Inc., Amphastar Pharmaeceutical Inc., Zhejiang xianju Pharmaceutical co., ltd., Eugia pharma, Mylan labs ltd.,Bayer Plc, Teva Pharms USA, PT Tunggal, Incepta Pharmaceuticals, and Baxter International Inc. are some of the major injectable contraceptives companies worldwide.
What factors are influencing injectable contraceptives industry growth in North America?
North America injectable contraceptives market size recorded USD 137.3 million in 2022 and is expected to reach USD 186.9 million by 2032 owing to the well-established healthcare systems and widespread access to variety of contraceptives in the region.
Why is the demand for progesterone-only injectables growing?
The progesterone-only type segment recorded 68.8% share of the injectable contraceptives industry in 2022 and will witness significant growth from 2023-2032 on account of its high level of efficacy and reliability in preventing unintended pregnancies.
How big is the injectable contraceptives market?
Injectable contraceptives industry size was valued at USD 339.5 million in 2022 and will register 3.5% CAGR from 2023-2032 due to the growing awareness about family planning worldwide.